Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

BACKGROUND: (18)F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast and axillary response at various time points dur...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Imaging
Autori principali: van Ramshorst, Mette S., Teixeira, Suzana C., Koolen, Bas B., Pengel, Kenneth E., Gilhuijs, Kenneth G., Wesseling, Jelle, Rodenhuis, Sjoerd, Valdés Olmos, Renato A., Rutgers, Emiel J., Vogel, Wouter V., Sonke, Gabe S., Vrancken Peeters, Marie-Jeanne T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445462/
https://ncbi.nlm.nih.gov/pubmed/28545563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-017-0117-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi